Date Filed | Type | Description |
02/12/2021 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Stemline Therapeutics, Inc. |
06/22/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
06/17/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
06/17/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
06/17/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
06/10/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/10/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/10/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/10/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/10/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/10/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/10/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
06/10/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
06/10/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
06/10/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
06/10/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
06/10/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
06/10/2020 |
8-K
| Resignation/termination of a director |
06/04/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
06/02/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
06/02/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
06/01/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
05/27/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
05/21/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
05/21/2020 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds STML, PTLA, and QES Shareholders About Its Ongoing Investigations |
05/19/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
05/19/2020 |
GN
| STEMLINE ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of STML and Encourages Investors to Contact the Firm |
05/19/2020 |
GN
| KLXE, FSB, PTLA, and STML SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers |
05/15/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
05/15/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
05/15/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of KLX Energy Services Holdings, Inc. (KLXE), Quintana Energy Services, Inc. (QES), Portola Pharmaceuticals, Inc. (PTLA), and Stemline Therapeutics, Inc. (STML) |
05/14/2020 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds STML, PTLA, QES, and TERP Shareholders About Its Ongoing Investigations |
05/13/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
05/12/2020 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
|